FDA Clears Bodyport Cardiac Scale to Monitor Heart Function, Fluid Status
The FDA has cleared the Bodyport Cardiac Scale to allow individuals w/ fluid mgmt conditions to assess measures of heart function & fluid.
Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has cleared the Bodyport Cardiac Scale to allow individuals w/ fluid mgmt conditions to assess measures of heart function & fluid.
Under the Jynneos EUA, intradermal administration of the vaccine has been authorized in individuals 18 years of age and older.
The FDA has approved Auvelity (dextromethorphan HBr-buproprion HCl) extended-release tablets for the treatment of major depressive disorder.
The FDA has approved Zynteglo (betibeglogene autotemcel) for the treatment of patients with beta-thalassemia who require RBC transfusions.
The FDA has accepted the NDA for fezolinetant for the treatment of moderate to severe vasomotor symptoms associated with menopause.